Search Press releases Keywords From To 19 Sep 2023 UCB Provides Update on U.S. Regulatory Review of Bimekizumab Read More 15 Sep 2023 UCB receives CHMP positive opinion of zilucoplan for the treatment of adults with generalized myasthenia gravis in Europe Read More 31 Aug 2023 UCB presents new data at 35th International Epilepsy Congress (IEC) highlighting important advancements across Fintepla[®]▼(fenfluramine) oral solution and broader epilepsies portfolio Read More 27 Jul 2023 UCB now at the inflection point – ready to start a new phase of growth Read More 18 Jul 2023 UCB Announces EU Regulatory Filing for Bimekizumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa Read More 30 Jun 2023 UCB Presents Latest Data from Generalized Myasthenia Gravis Portfolio at 9th Congress of the European Academy of Neurology (EAN) Meeting Read More Pagination First page Previous page Previous … Page 27 Page 28 Page 29 Page 30 Current page 31 Page 32 Page 33 Page 34 Page 35 … Page 31 of 63 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
